![Shinichiro Fuse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shinichiro Fuse
Director/Board Member at
Santa Ana Bio, Inc.
Profile
Dr. Shinichiro Fuse is a Partner and Managing Director at TPG Capital LLC.
He is on the Board of Directors at Santa Ana Bio, Inc. Dr. Fuse was previously employed as a Member-Supervisory Board by iOmx Therapeutics AG, a Managing Director by MPM BioImpact LLC, an Associate by PureTech Ventures LLC, and a Consultant by Clarion Healthcare Consulting.
He also served on the board at Orna Therapeutics, Inc. and Triplet Therapeutics, Inc. He received his undergraduate degree from Keio University, a graduate degree from the University of Tokyo and a doctorate degree from Dartmouth College.
Shinichiro Fuse active positions
| Companies | Position | Start |
|---|---|---|
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Director/Board Member | - |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital seeks investment opportunities in companies located across the globe. The firm focuses on companies operating in fields of wide range of sectors. It provides equity financing for buyout transactions. | Private Equity Investor | - |
Former positions of Shinichiro Fuse
| Companies | Position | End |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Investment Committee Member | 01/10/2021 |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Chief Executive Officer | - |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Private Equity Analyst | 02/07/2012 |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Director/Board Member | - |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Director/Board Member | - |
Training of Shinichiro Fuse
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
TPG Capital LLC
TPG Capital LLC Investment ManagersFinance TPG Capital seeks investment opportunities in companies located across the globe. The firm focuses on companies operating in fields of wide range of sectors. It provides equity financing for buyout transactions. | Finance |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keio University
 Keio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarion Healthcare Consulting | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Shinichiro Fuse
